3000+ Attendees, 450 Speakers, 12 Conference Tracks, 100+ Posters
 
MMTC15_Header  
MMTC M Header 

Cambridge Healthtech Institute’s Twelfth Annual

Molecular Diagnostics

The Industry Leader’s Networking Event

February 15-18, 2015 | Moscone North Convention Center | San Francisco, CA
Part of the 22nd Annual Molecular Medicine Tri-Conference

 

The growth in the diagnostics sector and personalized therapy is being driven by opportunities in molecular diagnostics.  Today, hospitals and healthcare providers need to stay competitive by taking on large-scale projects to match patients with targeted therapy using next generation sequencing and molecular profiling tools.  This conference will feature experts on business strategy, platform development, regulation and reimbursement who will outline the steps needed to take to achieve commercial success in the current environment.

Who should attend: VPs, Directors, Managers, CEOs, CSOs, Professors and Scientists from Diagnostic and Medical Device companies, Large Pharma, Biotechs and Academia working in fields of Diagnostics, Business Development, R&D, Chemistry, Clinical Research, in vitro Diagnostics, Personalized Healthcare, Process Development, and Oncology.

Topics will include, but are not limited to: 

  • Strategies for achieving payer coverage
  • FDA guidance for LDTs and NGS
  • New molecular tests that are changing patient care through molecular profiling, biomarker development and quantitative analysis
  • Commercialization approaches for product launch
  • Molecular testing for infectious diseases
  • Identifying novel druggable targets with non-coding RNA
  • Introducing new platforms for high-efficiency, fully automated, low-cost molecular testing
  • Translating genomic findings to clinicians

If you would like to submit a proposal to give a presentation at this meeting, please click here.

The deadline for submission is July 18, 2014. 

All proposals are subject to review by the Scientific Advisory Committee to ensure the highest quality of the conference program.  Please note that due to limited speaking slots, preference is given to pharmaceutical and biotech companies, regulators and those from academia. Additionally, vendors/consultants who provide products and services to these biopharmaceutical companies are offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

For more details on the conference, please contact:
Christina Lingham
Executive Director, Conferences
Cambridge Healthtech Institute
T: 781-972-5464
E: clingham@healthtech.com 

For partnering and sponsorship information, please contact:
Jon Stroup (Companies A-K)
Manager, Business Development
Cambridge Healthtech Institute
T: (+1) 781-972-5483
E: jstroup@healthtech.com 

Joseph Vacca (Companies L-Z) 
Manager, Business Development
Cambridge Healthtech Institute
T: (+1) 781.972.5431
E: jvacca@healthtech.com
 

 



Premier Sponsors:

Leica Biosystems 
 

 NanoString2   

 

Singulex 

 

Jackson Laboratory - small logo